It was interesting that PLGLB1 not only maintained a higher level during the three stages of COVID-19 compared with healthy controls (Figure 6A), but also increased in all severity groups (including the asymptomatic group) compared with non-COVID-19 controls (Figure 6B). This evidence concerns the gene PLGLB1 and COVID-19.